Vimarsana
Biggest News Aggregation in the World

Page 2 - Genome Aggregation Database News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genome Aggregation Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genome Aggregation Database Today - Breaking & Trending Today

Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence of ENPP1 Deficiency - Vimarsana News

Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence of ENPP1 Deficiency

- Article in Orphanet Journal of Rare Diseases estimates genetic prevalence of ENPP1 Deficiency at 1 in 64,000 pregnancies, more than tripling prior estimate - - Company estimates addressable patient... | December 5, 2022

AWS Launches Amazon Omics for Precision Medicine - Vimarsana News

AWS Launches Amazon Omics for Precision Medicine

AWS launches new service, Amazon Omics, to help bioinformaticians, researchers, and scientists store, query, and analyze genomic...

AWS launches Amazon Omics for precision medicine - Vimarsana News

AWS launches Amazon Omics for precision medicine

The cloud-based platform provides security, scale and the processing power needed for genomic data storage and analyses, eliminating the need for specialized infrastructure and workflows.

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease - Vimarsana News

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease

/PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl") a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with...

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease - Vimarsana News

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease

/PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl") a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with...